Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 13 of 13  Show

Literature citations Results

Citation
The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation.

German Mouse Clinic Consortium
Schmidt M.O., Garman K.A., Lee Y.G., Zuo C., Beck P.J., Tan M., Aguilar-Pimentel J.A., Ollert M., Schmidt-Weber C., Fuchs H. et al.

J. Invest. Dermatol. 138:179-188(2018) · Mapped (1)

Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing.

Al-Otaiby M., Tassi E., Schmidt M.O., Chien C.D., Baker T., Salas A.G., Xu J., Furlong M., Schlegel R., Riegel A.T. et al.

Am. J. Pathol. 180:1474-1484(2012) · Mapped (15)

Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome.

Ray P.E., Tassi E., Liu X.H., Wellstein A.

Am. J. Physiol. Regul. Integr. Comp. Physiol. 290:R105-13(2006) · Mapped (2)

Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways.

Tassi E., Zanon M., Vegetti C., Molla A., Bersani I., Perotti V., Pennati M., Zaffaroni N., Milella M., Ferrone S. et al.

Clin. Cancer Res. 18:3316-3327(2012) · Mapped (3)

Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients.

Tassi E., Braga M., Longhi R., Gavazzi F., Parmiani G., Di Carlo V., Protti M.P.

PLoS ONE 4:e7234-e7234(2009) · Mapped (4)

NFATc2 is a potential therapeutic target in human melanoma.

Perotti V., Baldassari P., Bersani I., Molla A., Vegetti C., Tassi E., Dal Col J., Dolcetti R., Anichini A., Mortarini R.

J. Invest. Dermatol. 132:2652-2660(2012) · Mapped (3)

Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display.

Xie B., Tassi E., Swift M.R., McDonnell K., Bowden E.T., Wang S., Ueda Y., Tomita Y., Riegel A.T., Wellstein A.

J. Biol. Chem. 281:1137-1144(2006) · UniProtKB (2) · Mapped (1)

Human JIK, a novel member of the STE20 kinase family that inhibits JNK and is negatively regulated by epidermal growth factor.

Tassi E., Biesova Z., Di Fiore P.P., Gutkind J.S., Wong W.T.

J. Biol. Chem. 274:33287-33295(1999) · UniProtKB (1)

Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism.

Tassi E., Garman K.A., Schmidt M.O., Ma X., Kabbara K.W., Uren A., Tomita Y., Goetz R., Mohammadi M., Wilcox C.S. et al.

Sci Rep 8:15973-15973(2018) · Mapped (8)

Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein.

Tassi E., Al-Attar A., Aigner A., Swift M.R., McDonnell K., Karavanov A., Wellstein A.

J. Biol. Chem. 276:40247-40253(2001) · UniProtKB (2) · Mapped (5)

Effect of FGF-binding protein 3 on vascular permeability.

Zhang W., Chen Y., Swift M.R., Tassi E., Stylianou D.C., Gibby K.A., Riegel A.T., Wellstein A.

J. Biol. Chem. 283:28329-28337(2008) · UniProtKB (2) · Mapped (5)

Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein).

Tassi E., Lai E.Y., Li L., Solis G., Chen Y., Kietzman W.E., Ray P.E., Riegel A.T., Welch W.J., Wilcox C.S. et al.

Hypertension 71:160-167(2018) · Mapped (1)

Binding specificity and in vivo targets of the EH domain, a novel protein-protein interaction module.

Salcini A.E., Confalonieri S., Doria M., Santolini E., Tassi E., Minenkova O., Cesareni G., Pelicci P.G., Di Fiore P.P.

Genes Dev. 11:2239-2249(1997) · UniProtKB (5) · Mapped (3)

1 to 13 of 13  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again